Search

everythinglearnresearchcommunity

for

Search:↓

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Two siblings both had a rare case of alopecia areata at the same time.

Gray hair regained color after thyroid hormone treatment.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Skin aging reflects overall body aging and can indicate internal health conditions.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Homeopathic treatment can help manage alopecia areata in children.

The document concludes that proper recognition and treatment of skin appendage disorders are important for management.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

Alopecia areata involves immune response and gene changes affecting hair loss.

Personalized treatment plans are important for people with alopecia areata.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

The document concludes that "Photodamage" and "Photoimmunology" are valuable resources, while "Pediatric Dermatopathology" and "Hair and Scalp Disorders" have limitations.

Melanocyte stem cells in hair follicles are key for hair color and could help treat greying and pigment disorders.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.